M&A
Cognizant acquires US digital video solutions company, Itaas
23 Apr 2014
The acquisition will enable Cognizant to capitalise on the growing demand for greater interactivity, higher personalisation, and innovative content delivery in the multi-screen and video market
Valeant tables hostile $45.7 bn bid for Botox maker Allergan
23 Apr 2014
Valeant Pharmaceuticals International Inc, Canada's biggest drug maker and one of the most aggressive acquirers, yesterday tabled a hostile $45.7-billion cash and stock bid for Botox maker Allergan Inc
European regulator approves Suntory's $13.6-bn Beam deal
22 Apr 2014
In recent years, Suntory has been making acquisitions and developing business partnerships with major beverage companies in a bid to rapidly expand its global footprint
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Valeant teams up with hedge fund to buy Botox maker Allergan for $42 bn
22 Apr 2014
News of the impending bid sent the stock price of Valeant and Allergan companies soaring in after-hours trading
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Latest articles
Featured articles
The remarkable Ratan Tata
By Kiron Kasbekar | 23 Oct 2024
One newspaper report of Ratan Tata’s passing away showed an old photo of him climbing into the cockpit of a Lockheed Martin F-16 fighter.
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation